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Abstract Numerous studies have shown that food pro-
teins may be a source of bioactive peptides. Those peptides
are encrypted in the protein sequence. They stay inactive
within the parental protein until release by proteolytic
enzymes (Mine and Kovacs-Nolan in Worlds Poult Sci J
62(1):87–95, 2006; Hartman and Miesel in Curr Opin
Biotechnol 18:163–169, 2007). Once released the bioactive
peptides exhibit several biofunctionalities and may serve
therapeutic roles in body systems. Opioid peptides, pep-
tides lowering high blood pressure, inhibiting platelet
aggregation as well as being carriers of metal ions
and peptides with immunostimulatory, antimicrobial and
antioxidant activities have been described (Hartman and
Miesel in Curr Opin Biotechnol 18:163–169, 2007). The
biofunctional abilities of the peptides have therefore
aroused a lot of scientific, technological and consumer
interest with respect to the role of dietary proteins in
controlling and influencing health (Mo¨ller et al. in Eur J
Nutr 47(4):171–182, 2008). Biopeptides may find wide
application in food production, the cosmetics industry as
well as in the prevention and treatment of various medical
conditions. They are manufactured by chemical and
biotechnological methods (Marx in Chem Eng News
83(11):17–24. 2005; Hancock and Sahl in Nat Biotechnol
24(12):1551–1557, 2006). Depending on specific needs
(food or pharmaceutical industry) different degrees of
peptide purifications are required. This paper discusses the
practicability of manufacturing bioactive peptides, espe-
cially from food proteins.
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Food protein enzymatic hydrolysis
Recently, there has been a significant increase of studies on
enzymatic hydrolysis (in vitro) to release bioactive pep-
tides from food proteins (Spellman et al. 2003). Bioactive
peptides are released from proteins during some food
processing such as cheese ripening or milk fermentation
(Hartman and Miesel 2007). The use of enzymatic hydro-
lysis is preferred, especially in food and pharmaceutical
industries, because of the lack of residual organic solvents
and toxic chemicals in the final peptide preparations (Agyei
and Danquah 2011).
The consequence of the proteolytic action is the change
in molecular conformation of native proteins and produc-
tion of functional and bioactive products (Panyam and
Kilara 1996; Adebiyi et al. 2008). Enzymatic hydrolysis is
a process conducted under mild conditions which can be
easily controlled and allows one to obtain products with
well-defined features (Clemente 2000; FitzGerald and
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O’Cuinn 2006). Most enzymatic modifications of dietary
proteins are carried out by enzymes such as pepsin,
bromelain, trypsin, chymotrypsin, papain or ficain under
their respective optimal pH and temperature conditions
(Chrzanowska 1998). However, the application of enzymes
can increase the cost of the process, which is why cheap
sources of them are preferred. One of the best sources of
animal origin proteinases are pancreases, by-products of the
meat industry ( _Zelazko et al. 2007). Also microorganisms
are a relatively cheap source of proteases. For example,
Neutrase, Subtilisin, Orientase, Protex 7L, Protamex 1.5
and proteases from lactic acid bacteria (LAB) are widely
used for the production of bioactive peptides (Chrzanowska
1998; Sakanaka and Tachibana 2006; Wagar et al. 2009).
Microbial proteases provide few advantages over proteases
from other sources. Bacterial cultivation costs are relatively
low (minimal nutritional requirements, short time of mat-
uration) and proteases, especially of the LAB, are expressed
on the cell membrane making purification protocols rela-
tively easy and cheap. Furthermore LAB and their products
are considered safe (generally recognized as safe, GRAS)
(Agyei and Danquah 2011).
The precursors of biopeptides may be proteins of animal
origin such as milk proteins (casein, whey protein), muscle
proteins (myosin, collagen) as well as of plant origin such as
soy protein (glycinin, b-conglycinin), wheat and rice pro-
tein (Gibbs et al. 2004; Ibrahim et al. 1998; Kim et al. 2007;
Kong et al. 2007; Li et al. 2007; Saiga et al. 2003). Because
of their potential as physiological modulators, as well as the
high safety profile, they can be used as components of
functional foods and nutraceuticals. Bioactive peptides can
be also released from protein by-products of food industry,
reducing the production costs with the added advantage of
an efficient waste disposal. Peptic hydrolysis of rapeseed
protein (oil industry waste) leads to the generation of pep-
tides possessing strong ACE inhibitory and DPPH radical
scavenging activity (Yoshie-Stark et al. 2006). Hydroly-
sates produced with Orientase and protease from Bacillus
sp. of delipidated egg yolk protein, as obtained by lecithin
extraction, exhibited DPPH and hydroxyl radical scaveng-
ing activity (Sakanaka and Tachibana 2006).
The in vitro enzymatic hydrolysis and the in situ
microbial fermentation of food proteins both give rise to
mixtures of peptides. However, the complexity of the
starting hydrolysate makes the purification process quite
demanding and time-consuming; in numerous situations
each biopeptide might require a complicated process pro-
tocol (Agyei and Danquah 2011). Currently, the standard
protocol for bioactive peptide isolation includes precipita-
tion of unhydrolysed protein (Graszkiewicz et al. 2007),
membrane filtration (ultrafiltration) (Xu et al. 2007), liquid
chromatography (including ion-exchange, gel filtration
chromatography (Xu et al. 2007; Amarowicz and Shahidi
1997) and in particular, reversed-phase high-performance
liquid chromatography (RP-HPLC) (Adebiyi et al. 2008).
Purification protocols for antioxidant peptides from the
papain hydrolysate of pork muscles described by Saiga
et al. (2003) involves cation (AG 50 W-X2 resin) with
subsequent anion exchange chromatography (AG 1-X4
resin), and the resulting fractions are further applied to an
ultrafiltration membrane (MW \ 500 Da) and finally sep-
arated on an RP-HPLC column. However, Adebiyi et al.
(2008) fractionated the rice bran hydrolysates to pure
antioxidative peptides by RP-HPLC on a Kaseigel ODS
resin, using a stepwise gradient of aqueous ethanol only.
This approach usually results in good results in laboratory
scale purification; however, sometimes it is not easy to
translate it into large scale production because of the poor
yields. On the other hand, the lower production costs as
compared to chemical synthesis of the biopeptides make
those techniques worthy of consideration (Agyei and
Danquah 2011).
In many cases in the food industry, whole hydrolysates
(unpurified bioactive peptides) are the main components of
functional food. Fermented milks such as Calpis AMEEL S
(Japan) and Evolus (Finland) or the energy drink Cho-
lesteBlock (Japan), which exert antihypertensive and anti-
hyperholesterolemic effects, respectively, are available on
the market. Pure peptides found application only in phar-
macy. A representational example is the LKPN peptide
named ‘‘Katshuobushi Oligopeptide’’ released upon
Thermolysin treatment of Bonito fish. It is an active com-
ponent of the antihypertensive drugs Vasotensin 120TTM,
PeptACETM and Peptides 90 (Hartman and Miesel 2007).
There are many advantages of natural peptides. They are
mainly toxicologically safe, have a wide spectra of thera-
peutic action, exhibit less side effects as compared to
synthetic drugs and are better absorbed in the intestinal
tract (Erdman et al. 2008; Agyei and Danquah 2011). For
example, ovokinin, a peptide isolated from the peptic
hydrolysate of egg white, reduces blood pressure, without
side effects or induction of hypotension. Therefore, it may
be administered to patients with moderate hypertension or
with regular blood pressure (Erdman et al. 2008). The
synthetic peptides have a prolonged retention time out of
body tissues and may also interact with other medications
used by patients (Erdman et al. 2008; Agyei and Danquah
2011).
The unavailability of large scale technologies and high
cost of purification techniques are limiting factors to the
commercialization of food-derived bioactive peptides.
Research on the isolation of bioactive peptides reducing
time and costs are continuously developing (Agyei and
Danquah 2011). One possible solution is the application of
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immobilized enzymes. Proteolysis on the resin enables
recycling of the enzyme and at the same time generation of
secondary metabolites originating from autolysis of
enzymes is avoided (Agyei and Danquah 2011). Immobi-
lized enzymes have been effectively used to produce bio-
active peptides from Brassica carinata proteins (Pedroche
et al. 2007).
Another common approach is the use of continuous
processes rather than conventional batch methods to
hydrolyse the proteins. Kapel et al. (2006) produced anti-
hypertensive and opioid peptides from Alfalfa (Medicago
sativa) white protein concentrate. Hydrolysis was carried
out in a reactor coupled to two tubular ultrafiltration
modules. Cui et al. (2011) effectively performed continu-
ous hydrolysis to obtain bioactive peptides from wheat
gluten. The permeate fractions showed antioxidant activi-
ties that were mostly due to the low molecular weight
peptides. The enzyme membrane reactor system offers
control of the reaction with minimized substrate and cat-
alyst losses, faster reactions and higher yields, cleaner
products and lower operating costs (Rios et al. 2004).
Food-derived biologically active peptides
Numerous food-derived peptides exhibiting activities such
as opiate, antithrombotic, anticancer, antihypertensive,
immunomodulation, mineral-binding, antimicrobial or
antioxidant properties have been reported (Hartman and
Miesel 2007).
Research has focused on novel peptides with pharma-
cological properties. The group of antithrombotic peptides
derived from bovine j-casein (106–116; 106–112;
112–166 and 113–116) are named casoplatelins. One of
them, Casopiastrin (ft106–116) released from j-casein
during the proteolytic action of trypsin, exerts antithrom-
botic activity by inhibition of the fibrinogen binding pro-
cess whereas another peptide (103–111) of this protein
inhibited platelet aggregation (Iwaniak and Minkiewicz
2007).
Short peptides with cationic and hydrophobic properties
are recognized as potential antibiotics. Peptides with anti-
microbial and antiviral activity have been reported for
certain food proteins. Lactoferricin B, comprising residues
from 17 to 41 in the sequence of milk lactoferrin, has been
found to exert antimicrobial activity. As a result of
aggregation of peptides in the cytoplasmic membrane,
channels are formed which destabilize bacterial mem-
branes thus leading to microbial cell death (Chrzanowska
1998). The same effect is observed for the 92-amino acid
ovotransferrin peptide, OTAP-92, which is capable of
killing gram-negative bacteria. It also shows antiviral
activity against Marek’s disease virus in chicken embryo
fibroblasts (Mine and Kovacs-Nolan 2006). A good
example of an antimicrobial peptide is a cysteine-rich
peptide obtained by hydrolysis of oysters with alcalase and
bromelain which inhibits the growth of both gram-positive
and gram-negative bacteria (Liu et al. 2008). Kobayashi
et al. (2004) isolated a highly glycosylated peptides from
ovomucin by pronase treatment and reported that peptide
exhibited antiadhesive and antiviral activity towards
bovine rotavirus, Newcastle and influenza viruses.
Milk proteins are a rich source of opioid peptides. Those
peptides are released from casein and whey protein. The
largest group are b-casomorphins released from b-casein.
They show the same amino terminal sequence (Tyr-Pro-
Pro-Fen); their bioactivity is determined by the presence of
tyrosine residues in the N-terminal position. Opioid pep-
tides act on the central nervous system, affect pain per-
ception and behaviour. These peptides also act locally in
the gastrointestinal system, e.g. they extend the transit time
of ingesta through the digestive tract (Chrzanowska 1998).
A number of studies have been performed on the
immunomodulatory activity of peptides (Quian et al. 2011;
Wagar et al. 2009). Many of them significantly enhance
lymphocyte proliferation, natural killer cell activity, and
the secretion of cell cytokines. Peptides derived from hen
egg ovomucoid hydrolysate induced T cell formation. Also
immunomodulating peptides were obtained from peptic
(CN77-84) and chymotryptic (CN126-134) hydrolysates of
ovalbumin (Mine and Kovacs-Nolan 2006).
Human digestive tract cancers are strongly influenced by
diet (Rose et al. 2007). Several peptides with anticancer-
ogenic activity have been found in food protein hydroly-
sates (Yang et al. 2008; Agyei and Danquah 2011). Egg
yolk proteins and their hydrolysates exhibit antitumour
activity by inhibiting tumour cell proliferation in the colon
(Ishikawa et al. 2009). Also hydrophobic peptides extracted
from soy sauce exert cytotoxic activity on human colon
carcinomas and mouse lymphoma cell lines (Yang et al.
2008).
Antidiabetic peptides have been found in egg white
hydrolysates obtained from alcalase digestion. The peptide
RVPSLM exhibited a-glucosidase inhibitory activity with
an IC50 value of 23.07 lmol/L (Yu et al. 2011).
Many peptides are multifunctional and exhibit more
than one activity. Peptides separated from beef sarcoplas-
mic protein enzymatic hydrolysate show ACE inhibitory,
antimicrobial and cancer cell cytotoxic effects (Yang et al.
2008). Other examples are oligophosphopeptides with
molecular masses of 1–3 kDa derived from tryptic hydro-
lysis of phosvitin. These peptides enhanced calcium bind-
ing capacity and inhibited the formation of insoluble
calcium phosphates. Oligophosphopeptides also increased
iron uptake and showed novel antioxidant activity against
oxidative stress in human intestinal epithelial cells in an in
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vitro assay using Caco-2 cells (Xu et al. 2007). All the
examples given above provide probable therapeutic roles
of bioactive peptides obtainable from food proteins. Pro-
teins and precursors of food-derived peptides are well-
tolerated by the human body and therefore their use in drug
development may reduce costs and duration of toxicolog-
ical studies during R & D and clinical trials (Agyei and
Danquah 2011).
Chemical synthesis of peptides
The past few decades have seen extraordinary progress in
the chemical synthesis of peptides because of an explosive
growth in biological research related to these molecules.
Chemical synthesis allows the systematic variation of
structure with the aim of developing peptides for thera-
peutic use (Kent 1988). Chemical synthesis of peptides is
widely used in structural biology, immunology, protein
engineering and biomedical research (Miranda and
Alewood 1998). The traditional solution chemical synthe-
sis is a time-consuming process and needs many toxic
reagents, which may contribute to significant environ-
mental pollution. Furthermore, it provides poor yields,
racemization reactions and peptide by-products (Guzma´n
et al. 2007; Shwan 2008). The synthesis of polypeptides on
a solid support is an alternative to traditional methods and
dramatically improves yields, decreases the amount of
chemicals used and considerably improves the fidelity of
peptide chain assembly (Miranda and Alewood 1998;
Guzma´n et al. 2007).
Advances in solid-phase peptide synthesis (SPPS) over
the past decade have encouraged increased efforts towards
the total chemical synthesis of large complex peptides and
small proteins. It leads to superior acylation rates, reduces
racemization and has higher solubility in the common
coupling solvents, e.g. DMF (Guzma´n et al. 2007).
Miranda and Alewood (1998) established highly efficient
chemical procedures (SPPS) that achieve chain assembly
rates of approximately 10–15 amino acid residues per hour,
thus underpinning the rapid chemical synthesis of long
polypeptides. They synthesized several small to medium
peptides, including the ‘‘difficult’’ C-terminal sequence of
HIV-1 proteinase (residues 81–99); fragment 65–74 of the
acyl carrier protein; conotoxin PnIA(A10L), a potent nic-
otinic receptor antagonist; and the pro-inflammatory che-
motactic protein CP10, an 88-residue protein, by means of
native chemical ligation.
Sequence analysis of bioactive peptides can be used to
predict the potential bioactivity. New peptides with
improved biological activity as compared to their natural
analogues can be designed. Chen et al. (1998) obtained 22
synthetic histidine-containing peptides with antioxidant
properties, which were designed on the basis of the peptide
(Leu-Leu-Pro-His-His) derived from proteolytic digests of
a soybean protein. Another opportunity offered by chemi-
cal synthesis is substitution of particular amino acids in the
peptide sequence, which can result in modulation or dif-
ferentiation of peptide function. Replacement of the
C-terminal phenylalanine by tryptophan in ovokinin (2–7),
one of the best characterized bioactive peptides of egg,
resulted in significant improvement of its antihypertensive
activity (Matoba et al. 2001; Yamada et al. 2002).
Replacement of the basic amino acids in particular posi-
tions of peptides increases their anticoagulant activity
(Atanassov and Tchorbanov 2009). The synthesis of ana-
logues of the antithrombotic antistasin, ghilantens and TAP
by studying the role of basic and D-amino acids at different
positions in the molecule for the anticoagulant activity has
been described in a series of publications (Atanassov and
Tchorbanov 2009).
The development of chemical synthesis leads to the
availability of novel multifunctional biopeptides. Gurevich
et al. (1997) developed a synthetic peptide containing both
the antiadhesive Arg-Gly-Asp (RGD) amino acid sequence
and a nitric oxide (NO) moiety with vasorelaxant proper-
ties. The RGD-NO peptide increased the antithrombotic
characteristics of the RGD peptide. This peptide also
caused relaxation of rat aortic rings (Gurevich et al. 1997).
Most therapeutic peptides manufactured by chemical
synthesis have two main applications as peptide drugs and
as peptides for diagnostic purposes. Currently many natural
peptide analogues like the antihypertensive RPFHP and
RPLKPW are available on the market (Goła˛b and Warwas,
2005; Erdman et al. 2008).
Molecular biology methods
Solid-phase peptide synthesis works quicker than classical
synthesis, although still much more slowly than a living
cell (Kent 1988). Currently, many studies are focusing on
the development of synthetic genes for the delivery and
expression of bioactive peptides or their precursors in
microbial cells. This could be a good alternative to food
protein hydrolysis because the amount of bioactive pep-
tides available in food products is limited by protein con-
centration. For example antimicrobial lactoferricin is
released during the enzymatic hydrolysis of milk lactofer-
rin; however, the concentration of lactoferrin is low in
bovine milk (Kim et al. 2006; Renye and Somkuti 2007).
The manufacture of larger amounts of peptides needed
for food supplementation may be possible by using food-
grade dairy fermentation bacteria as peptide production
systems. For example two peptides, the 11-residue anti-
microbial peptide from bovine lactoferrin (BL-11)
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(RRWQWRMKKLG) and the 12-residue ACE inhibitory
peptide from as1-casein (C-12) (FFVAPFPEVFGK), have
been cloned in Streptococcus thermophilus bacteria.
Nucleic acid sequences encoding the peptides were gen-
erated by overlapping PCR and were subsequently cloned
into a new expression vector (Renye and Somkuti 2007).
Lactoferricin, an antimicrobial peptide, was success-
fully multimerized and expressed in Escherichia coli
BL21(DE3). About 60 mg of pure peptide with a molecular
weight similar to that of the chemically synthesized lac-
toferricin was obtained from 1 L of E. coli culture (Kim
et al. 2006). The successful expression of the antimicrobial
peptide buforin II as a concatemeric multimer in E. coli
was also reported (Kim et al. 2006).
Another technique for manufacturing bioactive peptides
includes the expression of recombinant protein in the
microbial cell followed by the hydrolysis of the fusion
protein by microbial proteinase. For example recombinant
lactoferricin B was cleaved successfully to a novel
hybrid antimicrobial peptide LFT33 by enterokinase (Feng
et al. 2011).
Bioactive peptides can be obtained directly from living
organisms by the hydrolysis of proteins or by chemical
synthesis and these approaches are not cost-effective. A
biological expression system using genetic techniques
based on a fusion technology would be a more efficient
method for the production of bioactive peptides (Kim et al.
2006; Renye and Somkuti 2007). However, the molecular
biology research has led to the availability of amino acid
sequence data determined by the cloning and cDNA
sequencing of genes. However, in many cases, the proteins
themselves have never been isolated and their properties
are largely unknown (Kent 1988).
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